Results 261 to 270 of about 26,203 (316)
Some of the next articles are maybe not open access.

Related searches:

Erenumab for episodic migraine

Pain Management, 2022
In this review, the authors provide an overview of erenumab, a monoclonal antibody used for the preventative treatment of episodic migraine by targeting the CGRP pathway. Randomized controlled trials have shown that erenumab is associated with a statistically significant decrease in monthly migraine days in patients with episodic migraine at monthly ...
Abhigyan Datta   +5 more
openaire   +2 more sources

Episodic Migraine and POTS

Current Pain and Headache Reports, 2023
Migraine is prevalent in patients with postural orthostatic tachycardia syndrome (POTS). The purpose of this review is to summarize and interpret studies that examine stress response systems in patients with migraine, focusing on their relevance to the pathologies associated with POTS.
openaire   +2 more sources

Episodic daily migraine or episodic status migrainosus

Cephalalgia, 2018
Objective To report a case series of a novel migraine subtype, which we term as episodic status migrainosus (ESM), characterized by attacks of migraine exclusively lasting more than 72 hours. We hypothesized that this would represent a novel nosologic entity, possibly an unstable migraine phenotype with a high conversion rate to chronic migraine (CM ...
Tarun D, Singh   +2 more
openaire   +4 more sources

Hemiplegic migraine episode triggered by regadenoson

Journal of Nuclear Cardiology, 2022
SPECT and PET myocardial perfusion imaging (MPI) are widely used to evaluate patients for coronary artery disease. Regadenoson (a selective A2A adenosine receptor agonist) is a commonly used vasodilator agent for stress MPI because of its safety profile and ease of use. Common adverse reactions such as headache, shortness of breath, flushing, and chest
Mohammed, Elsadany   +3 more
openaire   +2 more sources

Preventive Treatment for Episodic Migraine

Neurologic Clinics, 2019
Episodic migraine is a debilitating condition. Preventive therapy is used to reduce frequency, duration, or severity of attacks. This review discusses principles of preventive treatment with a focus on preventive treatment options for people with episodic migraine.
Simy K, Parikh, Stephen D, Silberstein
openaire   +2 more sources

Erenumab for episodic migraine prophylaxis

Expert Review of Neurotherapeutics, 2019
Introduction: This paper reviews placebo-controlled randomized double-blind studies with erenumab for the prevention of migraine. Erenumab is a fully human monoclonal antibody (mAb), which specifically blocks the calcitonin gene-related peptide (GGRP) receptor.
Lucas Hendrik, Overeem   +2 more
openaire   +2 more sources

Episodic Unilateral Mydriasis and Migraine

American Journal of Ophthalmology, 1984
Seven patients (all female, ranging in age from 5 to 53 years) had typical migraine and episodic unilateral mydriasis. These mydriatic episodes, usually occurring during the headache, lasted from 15 minutes to 24 hours and had occurred for three months to 35 years. Three patients had suffered from car sickness as children and there was a family history
D, Woods, P S, O'Connor, R, Fleming
openaire   +2 more sources

Home - About - Disclaimer - Privacy